PER
Click for more information
6.90% 8.1¢ percheron therapeutics limited

UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-31

  1. dalts66
    4,312 Posts.
    lightbulb Created with Sketch. 2015
    clock Created with Sketch.
    11/01/22
    03:00
    Post #: 58765139
    https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-gene-therapy-srp-9001-shows-statistically

    Sarepta stating their gene therapy is showing statistical significant results in 48 month trial.
    ANP Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.006(6.90%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.7¢ 8.7¢ 8.1¢ $154.2K 1.820M

Buyers (Bids)

No. Vol. Price($)
2 33824 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 275242 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.